Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
losartan (cozaar) (1 trial)
shenyankangfu (2 trials)
Glomerulonephritis (Phase 4)
Kidney Diseases (Phase 4)
Proteinuria (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Trials (2 total)
Trial APIs (2 total)